Drug Type Bispecific antibody |
Synonyms- |
Target |
Mechanism CagA inhibitors(S100 calcium binding protein A8 inhibitors), NIF inhibitors(S100 calcium binding protein A9 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | JP | 31 Dec 2021 | |
Inflammation | Preclinical | JP | 31 Dec 2021 |